BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person engagement across the life sciences industry.

The event is attended by an audience of early stage and emerging life sciences R&D Companies, investors, big pharma, and other valued partners throughout the life sciences ecosystem. The conference features a focused, relevant, and stimulating programme, led by great speakers, who bring their knowledge, expertise, and vision to the fore in exciting, high-quality sessions.

Interacting with new companies each year is something we believe to be a critical attribute of a successful conference and we work hard to ensure that a substantial and fresh line-up of investable opportunities and collaboration possibilities are showcased.

The Swiss Biotech Day has become one of the leading biotechnology conferences in Europe and a fixed date in the community’s calendar. In 2022, the conference highlighted the impressive growth of the Swiss biotech industry and presented an exciting program with ideal networking opportunities for over 1,100 participants from across the globe.

In 2023, the Swiss Biotech Day will again offer high-level experts from the life sciences industry the space and the time (one and a half days) to network, discuss and discover trends in R&D, manufacturing, data management, artificial intelligence and innovative financing. In addition, international biotech delegations can visit the “Global Village” to strengthen their ties with Switzerland as a biotech hub and promote cross-border investments, public-private partnerships, research and development collaborations and exchange of talent. 

The German Biotechnology Days (DBT) is the national forum for the German biotechnology industry. The DBT brings together entrepreneurs with scientists and partners from politics, funding institutions and administration. The two-day program highlights the diverse fields of application and the potential of biotechnology, from health research to the bioeconomy.

The German Biotechnology Days are jointly organised by BIO Deutschland and the Council of German BioRegions.

Ardena will be participating in this event to showcase our services, in particular our bioanalytical expertise.

This conference is an exclusive global partnering forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Join us this February , where industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers from around the globe.

Meet Ardena at Europe’s largest springtime partnering event.

BIO-Europe Spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.

Cell & Gene therapy continues to be one of fastest growing spaces in life sciences with RNA dominating a lot of innovations in genetic medicine. There are now over 800 RNA based therapeutics and vaccines already in early stage clinical development across mRNA, RNAi, antisense oligonucleotides, & wider nucleic acids.

Our understanding of RNA chemistry continues to mature. Delivery tools are increasingly sophisticated and impactful. Advances in genomics and gene editing are driving new approaches. And exciting work targeting RNA with small molecules and non-linear RNAs are emerging.

With that in mind, we can’t wait to bring the community together, face-to-face, for the second annual RNA Leaders Europe Congress. You’ll hear the latest advances in RNA chemistry, get clinical updates from the companies developing new therapies and source the partners who are helping to deliver drugs to patients.

DCAT Week is the premier global event held annually in New York City for companies engaged in the Bio/Pharmaceutical Manufacturing Value Chain. It is hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.

Our commitment at Ardena is to assist our clients in advancing their drugs to the clinic and providing exceptional service. We are excited to engage with both our customers and fellow professionals in the industry, exchanging knowledge about recent advancements and sharing our expertise at this event.

Representing Ardena at the event will be our Vice President for Business Development for North America, Steve Kendall. He is looking forward to meeting with industry colleagues and discussing how Ardena can help them achieve their drug development goals. If you are attending DCAT Week, please fill the form to schedule a meeting.

BIO One-on-One Partnering unifies access to partnering for the life science industry. You can efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders, regardless of whether you are registered for a specific event during JPM Week.

Biotech Showcase is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering them a unique opportunity to showcase their innovations and engage one-to-one with investors and biopharmaceutical executives.